Crexont ER 70 MG-280 MG cap 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Q06
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,232
Award facts
- Contract value 100% obligated
- $1,231.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,231.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for CREXONT ER 70 mg-280 mg capsules (120-count supply). This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 28, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999.999 billion ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine fulfillment under this prime contract vehicle, which positions AmerisourceBergen as a key supplier within DLA's pharmaceutical supply chain network.
Quick answers
Who was awarded contract SPE2DR26F5Q06?
SPE2DR26F5Q06 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F5Q06 worth?
The government has obligated $1,232 on SPE2DR26F5Q06.
Is contract SPE2DR26F5Q06 an order under another contract?
Yes. SPE2DR26F5Q06 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Q06 competed?
The extent of competition for SPE2DR26F5Q06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award